Manufacturer's investigation conclusion: a direct correlation between heartmate (hm) 3 left ventricular assist system (lvas), serial number (b)(6), and the reported gastrointestinal (gi) bleeding and patient outcome could not be conclusively determined through this evaluation.Review of the submitted log files revealed the device operating as expected.Of note, there were numerous pulsatility index (pi) events that filled the majority of the controller event log file and would have overwritten older data, per design.No notable events or alarms were captured.It was later reported that the patient expired on (b)(6) 2023.Multiple attempts for additional information were sent to the customer; however, no further information has been provided at this time.No product was returned for investigation.The relevant sections of the device history records for (b)(6) were reviewed and showed no deviations from manufacturing or quality assurance specifications.The heartmate 3 left ventricular assist system (lvas) instructions for use (ifu), rev.C, and the heartmate 3 patient handbook, rev.D, are currently available.Section 1 of this document lists adverse events, including bleeding and death, that may be associated with the use of the heartmate 3 left ventricular assist system.Section 4 explains that pi events are assumed by the system during cases when there are sudden and substantial changes in the pulsatility index.These events are also referred to as pi events, and may be initiated for reasons other than true pi events.Some reasons include sudden changes in a patient¿s volume status, arrhythmias, sudden changes in power, and sudden changes in pump speed.Section 6, ¿patient care and management¿ (under ¿anticoagulation¿), also provides the recommended anticoagulation regimen, including international normalized ratio (inr) range, as well as suggested anticoagulation modifications.No further information was provided.The manufacturer is closing the file on this event.
|